Your browser doesn't support javascript.
loading
Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.
Brehm, Thomas Theo; Pfefferle, Susanne; von Possel, Ronald; Karolyi, Mario; Zoufaly, Alexander; Wichmann, Dominic; Kobbe, Robin; Emmerich, Petra; Nörz, Dominik; Aepfelbacher, Martin; Schulze Zur Wiesch, Julian; Addo, Marylyn M; Schmiedel, Stefan; Lütgehetmann, Marc.
Afiliación
  • Brehm TT; Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pfefferle S; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel Riems, Hamburg, Germany.
  • von Possel R; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel Riems, Hamburg, Germany.
  • Karolyi M; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Zoufaly A; Center for Diagnostics, Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wichmann D; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Kobbe R; Department of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, Rostock, Germany.
  • Emmerich P; Department of Medicine 4, Klinik Favoriten, Vienna, Austria.
  • Nörz D; Department of Medicine 4, Klinik Favoriten, Vienna, Austria.
  • Aepfelbacher M; Faculty of Medicine, Sigmund Freud University, Vienna, Austria.
  • Schulze Zur Wiesch J; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Addo MM; Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schmiedel S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Lütgehetmann M; Department of Tropical Medicine and Infectious Diseases, Center of Internal Medicine II, University of Rostock, Rostock, Germany.
J Med Virol ; 94(10): 5038-5043, 2022 10.
Article en En | MEDLINE | ID: mdl-35662058
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2022 Tipo del documento: Article País de afiliación: Alemania